Michael Maes, Raz Yirmyia, Jens Noraberg, S. Brené, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, M. Maj
2009.3.1METABOLIC BRAIN DISEASE
tlooto Summary
Screening for inflammatory and neurodegenerative processes in depression will allow to discover new I&ND biomarkers, both at the level of gene expression and the phenotype, and elucidate the underlying molecular I &ND pathways causing depression; identify new therapeutic targets in the I& ND pathways; develop new anti-I&ND drugs for these targets; and select existingAnti-I &ND drugs or substances that could augment the efficacy of antidepressants.
Abstract
Abstract is not available.
Citation format
MAES, Michael, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. METABOLIC BRAIN DISEASE, 2009, 24: 27–53.